$LLY

‘Retatrutide reveals significant drops in blood pressure, triglycerides, non-HDL cholesterol, waist circumference…’ Innovation, not the FDA or Congress, is saving healthcare. We were bearish this name when it was $1 Tn market cap, turned bullish a few weeks ago when it was dancing around the 200 DMA. Important to be mentally flexible. Healthcare stocks could do quite well esp with midterms. $LLY